Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Dugo, Matteo"'
Autor:
Bosi C; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Bartha Á; Department of Bioinformatics, Semmelweis University, Tűzoltó Utca 7-9, 1094 Budapest, Hungary; Research Centre for Natural Sciences, Oncology Biomarker Research Group, Institute of Molecular Life Sciences, Eötvös Loránd Research Network, Magyar Tudósok Körútja 2, 1117 Budapest, Hungary., Galbardi B; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Notini G; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Naldini MM; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Licata L; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Viale G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Mariani M; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Pistilli B; Department of Medical Oncology, Gustave Roussy Cancer Center, Villejuif, France., Ali HR; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK; Department of Histopathology, Addenbrookes Hospital, Cambridge, UK., André F; Department of Medical Oncology, Gustave Roussy Cancer Center, Villejuif, France., Piras M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Callari M; Fondazione Michelangelo, Milan, Italy., Barreca M; Fondazione Michelangelo, Milan, Italy., Locatelli A; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Viganò L; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Criscitiello C; Division of Early Drug Development, European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy., Pusztai L; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, New Haven, CT, USA., Curigliano G; Division of Early Drug Development, European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy., Győrffy B; Department of Bioinformatics, Semmelweis University, Tűzoltó Utca 7-9, 1094 Budapest, Hungary; Research Centre for Natural Sciences, Oncology Biomarker Research Group, Institute of Molecular Life Sciences, Eötvös Loránd Research Network, Magyar Tudósok Körútja 2, 1117 Budapest, Hungary., Dugo M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: dugo.matteo@hsr.it., Bianchini G; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: bianchini.giampaolo@hsr.it.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Dec; Vol. 195, pp. 113379. Date of Electronic Publication: 2023 Oct 11.
Autor:
El Bezawy R; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Percio S; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Ciniselli CM; Bioinformatics and Biostatistics Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., De Cesare M; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Colella G; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Dugo M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, 20132, Milan, Italy., Veneroni S; Biomarkers Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Doldi V; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Martini S; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Baratti D; Peritoneal Surface Malignancies Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Kusamura S; Peritoneal Surface Malignancies Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Verderio P; Bioinformatics and Biostatistics Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Deraco M; Peritoneal Surface Malignancies Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Gandellini P; Department of Biosciences, University of Milan, 20133, Milan, Italy., Zaffaroni N; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy. nadia.zaffaroni@istitutotumori.mi.it., Zuco V; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy.
Publikováno v:
Cancer gene therapy [Cancer Gene Ther] 2022 Oct; Vol. 29 (10), pp. 1394-1404. Date of Electronic Publication: 2022 Mar 29.
Autor:
Fina E; Biomarkers Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy. emanuela.fina@humanitasresearch.it.; Current affiliation: Humanitas Research Center, IRCCS Humanitas Research Hospital, via Manzoni 56, Rozzano, 20089, Milan, Italy. emanuela.fina@humanitasresearch.it., Cleris L; Biomarkers Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy., Dugo M; Platform of Integrated Biology, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.; Current affiliation: Department of Medical Oncology, IRCCS Ospedale San Raffaele, via Olgettina 60, 20132, Milan, Italy., Lecchi M; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Ciniselli CM; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Lecis D; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Bianchi GV; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Verderio P; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Daidone MG; Biomarkers Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy., Cappelletti V; Biomarkers Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy. vera.cappelletti@istitutotumori.mi.it.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2022 Feb 25; Vol. 41 (1), pp. 78. Date of Electronic Publication: 2022 Feb 25.
Autor:
Verri C; Department of Experimental Oncology and Molecular Medicine, Unit of Tumour Genomics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Borzi C; Department of Experimental Oncology and Molecular Medicine, Unit of Tumour Genomics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Holscher T; Gensignia Life Sciences, Inc., San Diego, California., Dugo M; Department of Experimental Oncology and Molecular Medicine, Unit of Functional Genomics and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Devecchi A; Department of Experimental Oncology and Molecular Medicine, Unit of Functional Genomics and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Drake K; Gensignia Life Sciences, Inc., San Diego, California., Sestini S; Thoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Suatoni P; Thoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Romeo E; Gensignia Life Sciences, Inc., San Diego, California., Sozzi G; Department of Experimental Oncology and Molecular Medicine, Unit of Tumour Genomics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: gabriella.sozzi@istitutotumori.mi.it., Pastorino U; Thoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Boeri M; Department of Experimental Oncology and Molecular Medicine, Unit of Tumour Genomics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2017 Jun; Vol. 12 (6), pp. 922-931. Date of Electronic Publication: 2017 Mar 14.
Autor:
Pintarelli G; Department of Predictive and Preventive Medicine, Milan, Italy., Cotroneo CE; Department of Predictive and Preventive Medicine, Milan, Italy., Noci S; Department of Predictive and Preventive Medicine, Milan, Italy., Dugo M; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Galvan A; Department of Predictive and Preventive Medicine, Milan, Italy., Delli Carpini S; Genomics of Renal Diseases and Hypertension Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Citterio L; Genomics of Renal Diseases and Hypertension Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Manunta P; School of Nephrology, Università Vita-Salute San Raffaele, Milan, Italy., Incarbone M; Department of Surgery, Ospedale San Giuseppe, Milan, Italy., Tosi D; Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy., Santambrogio L; Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy., Dragani TA; Department of Predictive and Preventive Medicine, Milan, Italy., Colombo F; Department of Predictive and Preventive Medicine, Milan, Italy.
Publikováno v:
Scientific reports [Sci Rep] 2017 Feb 09; Vol. 7, pp. 42185. Date of Electronic Publication: 2017 Feb 09.
Autor:
Cotroneo CE; Department of Predictive and Preventive Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy., Dassano A; Department of Predictive and Preventive Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy., Colombo F; Department of Predictive and Preventive Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy., Pettinicchio A; Department of Predictive and Preventive Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy., Lecis D; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy., Dragani TA; Department of Predictive and Preventive Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: tommaso.dragani@istitutotumori.mi.it., Manenti G; Department of Predictive and Preventive Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Cancer letters [Cancer Lett] 2016 Jun 01; Vol. 375 (2), pp. 221-230. Date of Electronic Publication: 2016 Mar 07.
Autor:
Galvan A; Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy., Colombo F, Frullanti E, Dassano A, Noci S, Wang Y, Eisen T, Matakidou A, Tomasello L, Vezzalini M, Sorio C, Dugo M, Ambrogi F, Iacobucci I, Martinelli G, Incarbone M, Alloisio M, Nosotti M, Tosi D, Santambrogio L, Pelosi G, Pastorino U, Houlston RS, Dragani TA
Publikováno v:
International journal of cancer [Int J Cancer] 2015 Mar 01; Vol. 136 (5), pp. E262-71. Date of Electronic Publication: 2014 Sep 19.
Autor:
Galvan A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Frullanti E, Anderlini M, Manenti G, Noci S, Dugo M, Ambrogi F, De Cecco L, Spinelli R, Piazza R, Pirola A, Gambacorti-Passerini C, Incarbone M, Alloisio M, Tosi D, Nosotti M, Santambrogio L, Pastorino U, Dragani TA
Publikováno v:
Carcinogenesis [Carcinogenesis] 2013 Dec; Vol. 34 (12), pp. 2767-73. Date of Electronic Publication: 2013 Aug 25.
Autor:
Lorena Citterio, Matteo Dugo, Chiara E. Cotroneo, Tommaso A. Dragani, Paolo Manunta, Matteo Incarbone, Francesca Colombo, Luigi Santambrogio, Simona Delli Carpini, Giulia Pintarelli, Antonella Galvan, Davide Tosi, Sara Noci
Publikováno v:
Scientific reports (Nature Publishing Group) 7 (2017). doi:10.1038/srep42185
info:cnr-pdr/source/autori:Pintarelli, Giulia; Cotroneo, Chiara Elisabetta; Noci, Sara; Dugo, Matteo; Galvan, Antonella; Delli Carpini, Simona; Citterio, Lorena; Manunta, Paolo; Incarbone, Matteo; Tosi, Davide; Santambrogio, Luigi; Dragani, Tommaso A.; Colombo, Francesca/titolo:Genetic susceptibility variants for lung cancer: Replication study and assessment as expression quantitative trait loci/doi:10.1038%2Fsrep42185/rivista:Scientific reports (Nature Publishing Group)/anno:2017/pagina_da:/pagina_a:/intervallo_pagine:/volume:7
Scientific Reports
info:cnr-pdr/source/autori:Pintarelli, Giulia; Cotroneo, Chiara Elisabetta; Noci, Sara; Dugo, Matteo; Galvan, Antonella; Delli Carpini, Simona; Citterio, Lorena; Manunta, Paolo; Incarbone, Matteo; Tosi, Davide; Santambrogio, Luigi; Dragani, Tommaso A.; Colombo, Francesca/titolo:Genetic susceptibility variants for lung cancer: Replication study and assessment as expression quantitative trait loci/doi:10.1038%2Fsrep42185/rivista:Scientific reports (Nature Publishing Group)/anno:2017/pagina_da:/pagina_a:/intervallo_pagine:/volume:7
Scientific Reports
Many single nucleotide polymorphisms (SNPs) have been associated with lung cancer but lack confirmation and functional characterization. We retested the association of 56 candidate SNPs with lung adenocarcinoma risk and overall survival in a cohort o